The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment preferences in advanced pancreatic ductal adenocarcinoma (PDAC) from qualitative patient (PT), caregiver (CG), and oncologist (OC) interviews.
 
Mark Lewis
Employment - Medscape
Honoraria - Foundation Medicine
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; Natera; Tersera
Speakers' Bureau - Astellas Scientific and Medical Affairs Inc; AstraZeneca/Daiichi Sankyo; Natera; Seagen
Other Relationship - Eisai; Foundation Medicine; Medscape
 
Keila Meginnis
Employment - Evidera
Consulting or Advisory Role - Evadera (I)
Research Funding - Evidera (Inst)
 
Rupali Fuldeore
Employment - Astellas Pharma
 
Myrto Trapali
Employment - Evidera
Consulting or Advisory Role - Evidera
Research Funding - Evidera
 
Ashley Samuelson
Employment - Evidera
Consulting or Advisory Role - Evidera
Research Funding - Evidera
 
Arianne Schild
Employment - Astellas Pharma
Research Funding - Astellas Pharma
 
Anica Lamkin
Consulting or Advisory Role - Norartis, Pfizer
 
Janet deGrazia
No Relationships to Disclose
 
Katrina Harmon
Employment - Trinity Health
 
Vincent Picozzi
Stock and Other Ownership Interests - Amgen; Cigna; Iovance Biotherapeutics; Johnson & Johnson; McKesson; Thermo Fisher Scientific
Research Funding - Abbvie; Amal Therapeutics; Astellas Pharma; FibroGen; Ipsen; Novocure
 
Jennifer Whitty
Employment - Evidera
Stock and Other Ownership Interests - Thermo Fisher Scientific
Consulting or Advisory Role - Evidera (Inst)
Research Funding - Evidera (Inst)